Remdesivir still looks promising.🧪🧫
RT @CarlosdelRio7: Compassionate Use of Remdesivir for Patients with Severe #COVIDー19 | @NEJM in this cohort of patients benefits were ob…
How on Earth did this get a NEJM publication?
RT @StearnsLab: A Gilead drug, GS-5734 (remdesivir) was approved in mid-March for compassionate use in severe #COVID19 cases. Some data are…
Even though this isn't a clinical trial, its an encouraging news.
RT @AndyBiotech: NEJM report on compassionate use of Remdesivir for 53 patients with severe #COVID19 https://t.co/gL0QKtw39L … 36/53 (68%)…
Important paper. OK this is not an RCT, but nevertheless only 18% mortality in COVID-19 ventilated patients is quite impressive. I am aware that many more patients have been treated with Remdesivir in the compassionate use program. Can we see the data? htt
RT @laoneill111: First study on resdemivir (anti-viral) in COVID19. Eminent journal (NEJM). Very sick patients on ventilation 13% fatality…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @LeventalLab: OH WOW! This looks to be fantastic news! No wonder Gilead was ramping up production. https://t.co/zAHnW1CGnF
RT @EMSwami: Interesting data on compassionate use Remdesivir in severe #COVID19 https://t.co/emNbrG4tVC Caution: not for all comers - Smal…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
68% Improvement in Covid 19 Patients Treated with Remdesivir https://t.co/90lu3Oi3tS
RT @malkadav: Premiers résultats encourageants de l’antiviral #remdesivir pour le #covid19, en particulier et y compris dans les cas sévère…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @dr_michaelmarks: Conclusion Remdesivir #COVID19 @nejm https://t.co/oUKDAiA3SN Almost nil. >10% excluded analysis. No placebo/active com…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @StearnsLab: A Gilead drug, GS-5734 (remdesivir) was approved in mid-March for compassionate use in severe #COVID19 cases. Some data are…
RT @CarlosdelRio7: Compassionate Use of Remdesivir for Patients with Severe #COVIDー19 | @NEJM in this cohort of patients benefits were ob…
A Gilead drug, GS-5734 (remdesivir) was approved in mid-March for compassionate use in severe #COVID19 cases. Some data are now available and it looks promising. https://t.co/TylRfKw5Wr
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Compassionate Use of Remdesivir for Patients with Severe #COVID19 ca. 2020 from @NEJM 👉🏼 https://t.co/LrPBo3tpSn https://t.co/JcCX2OTjSU
Encouraging result for remdesivir $Gild for #COVID19 therapy.
RT @ahmedjo70s: يالله يا ولاد خبر كويس أهو..ال Remdesivir بتاع جليد..الشركة اللي عملت أدوية ڤيروس سي..جايب نتيجة كويسة في الحالات الحادة ..…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @malkadav: Premiers résultats encourageants de l’antiviral #remdesivir pour le #covid19, en particulier et y compris dans les cas sévère…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
That’s why all this focus on HCQ is meaning we are ignoring possibly more effective treatments in favor of something that could be harmful and has little benefit.
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @malkadav: Premiers résultats encourageants de l’antiviral #remdesivir pour le #covid19, en particulier et y compris dans les cas sévère…
RT @CMichaelGibson: Encouraging data for compassionate use of #Remdesivir in #coronavirus patients. 57% of those treated with extubated whi…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Jesus, what's the point? The decision not to randomise in these circumstances is completely indefensible. The investigators have no idea if they are helping or harming.
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @jsmadero: Uso abierto de remdesivir en pac con enfermedad grave por Covid-19. Mortalidad 18% en pac con ventilación mecánica. Compassi…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @davidrliu: Encouraging clinical results from remdesivir to treat very ill #COVID19 patients. Next: randomized, blinded, controlled tria…
RT @CarlosdelRio7: Compassionate Use of Remdesivir for Patients with Severe #COVIDー19 | @NEJM in this cohort of patients benefits were ob…
Doesn’t this look similar to what we would expect without any Remdesivir? Am I missing something? @NEJM #COVID19 #medtwitter https://t.co/V72eOOOvmF
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @CarlosdelRio7: Compassionate Use of Remdesivir for Patients with Severe #COVIDー19 | @NEJM in this cohort of patients benefits were ob…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Report in NEJM on remdesivir in covid-19 patients. "compassionate use" cases. Authors think potentially helpful but don't have data to say for sure. https://t.co/J5xBxAnrkX
RT @GermHunterMD: Here is a study. It is uncontrolled. It is not good. What are we doing here?
RT @csentropy: Great news on Remdesivir: https://t.co/HwduOTk5Jx Dramatic effect matters
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @CMichaelGibson: Encouraging data for compassionate use of #Remdesivir in #coronavirus patients. 57% of those treated with extubated whi…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Remdesivir: improvement in oxygen-support status was observed in 68% of patients, and overall mortality was 13% over a median follow-up of 18 days. Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/bpOgW2DOe4
RT @accpinfdprn: 📄 New today from @NEJM on @GileadSciences’s remdesivir for #COVID19 📲 https://t.co/LPlhryLTAW No comparator. 68% had cl…
RT @rising_serpent: In this cohort of patients hospitalized for severe Covid19 who were treated with compassionate-use remdesivir, clinical…
Hot off the presses: https://t.co/eycqtP2rSt
重症53例のレムデシビル使用経験(9例は日本) 約7割が改善。死亡率は侵襲的補助換気有=18%、無=5% https://t.co/xb7yVC9jIV
New from @NEJM: "Compassionate Use of Remdesivir for Patients with Severe Covid-19." https://t.co/Sc3ePkhd0G
RT @CMichaelGibson: Encouraging data for compassionate use of #Remdesivir in #coronavirus patients. 57% of those treated with extubated whi…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @Nat_anest: В NEJM сегодня опубликовали первый отчёт о применении Ремдесивира 53-и пациентам с тяжёлым течение Covid. Клиническое улучше…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @ahmedjo70s: يالله يا ولاد خبر كويس أهو..ال Remdesivir بتاع جليد..الشركة اللي عملت أدوية ڤيروس سي..جايب نتيجة كويسة في الحالات الحادة ..…
RT @eeeejjjaaaa: If you compare the crit ill pt requiring invasive ventilation, 6/34 (18%) died, compared to 44/67 (66%) died in this paper…
RT @alidadban: Ok. Very ill patients. Now we need a control group. Waiting for #Discovery study results. But there may be something there.…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/BuSpsnXTv5
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/lhaj1JtCpL
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @neerajaiims: Just in @NEJM: Compassionate use of Remdesivir, a viral RNA polymerase inhibitor, results in clinical improvement in 68% h…
RT @dr_michaelmarks: Conclusion Remdesivir #COVID19 @nejm https://t.co/oUKDAiA3SN Almost nil. >10% excluded analysis. No placebo/active com…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Remdesivir
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @laoneill111: First study on resdemivir (anti-viral) in COVID19. Eminent journal (NEJM). Very sick patients on ventilation 13% fatality…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @CMichaelGibson: Encouraging data for compassionate use of #Remdesivir in #coronavirus patients. 57% of those treated with extubated whi…
RT @megtirrell: From NEJM article on compassionate use of Gilead’s remdesivir, a breakdown of each patient’s improvement level https://t.co…
RT @andersskyrud: Hva skal liksom denne studien tilføre, og hvorfor er den publisert i NEJM? Den har ikke kontroll-arm og ville nesten uans…
A cohort is a Roman military unit of six centuries, one tenth of a legion.
RT @krychtiukmd: Compassionate Use of Remdesivir for Patients with Severe Covid-19 Analysis of 61 patients receiving #remdesivir for #COV…
RT @romeerizwan: Encouraging results with Remdesivir #COVID19 . ‘68% had an improvement in oxygen-support class, including 17 of 30 patient…
RT @megtirrell: From NEJM article on compassionate use of Gilead’s remdesivir, a breakdown of each patient’s improvement level https://t.co…
Compassionate Use of Remdesivir for Patients with Severe #COVIDー19 | @NEJM in this cohort of patients benefits were observed with use of Remdesivir. https://t.co/IusQrPHS2X
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Are these good enough news? I am not convinced. Really need to wait for the proper randomised clinical trials... #COVID19 https://t.co/T83efqugSq